title: Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
authors.affiliation: Centro Trapianti Fegato, Ospedale Maggiore IRCCS Policlinico di Milano, Italy.
authors.forename: U
authors.initials: U
authors.lastname: Maggi
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: A
authors.initials: A
authors.lastname: Vannelli
authors.forename: L
authors.initials: L
authors.lastname: Caccamo
authors.forename: S
authors.initials: S
authors.lastname: Gatti
authors.forename: G
authors.initials: G
authors.lastname: Paone
authors.forename: P
authors.initials: P
authors.lastname: Reggiani
authors.forename: E
authors.initials: E
authors.lastname: Melada
authors.forename: L
authors.initials: L
authors.lastname: Latham
authors.forename: P
authors.initials: P
authors.lastname: Andreani
authors.forename: L R
authors.initials: LR
authors.lastname: Fassati
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology*; D006509:Hepatitis B / Q000453:epidemiology*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus